• Most Popular
  • Most Shared

Enzon gets full FDA okay on meningitis drug

Fri Apr 20, 2007 8:24am EDT

Stocks

   

Regulatory News

April 20 (Reuters) - Enzon Pharmaceuticals Inc. (ENZN.O) said the U.S. Food and Drug Administration has granted full approval for DepoCyt, its drug used for the treatment of a life-threatening complication of meningitis called lymphomatous meningitis.

(Reporting by Supantha Mukherjee in Bangalore)

((Editing by Anil Kumar; Reuters Messaging: supantha.mukherjee.reuters.com@reuters.net; within U.S.+1 646 223 8780; outside U.S. +91 80 4135 5800)) Keywords: ENZON FDA/

(C) Reuters 2007. All rights reserved. Republication or redistribution ofReuters content, including by caching, framing or similar means, is expresslyprohibited without the prior written consent of Reuters. Reuters and the Reuterssphere logo are registered trademarks and trademarks of the Reuters group ofcompanies around the world.nWNAS7034
Regulatory News


More from Reuters

Photo

Time Warner Cable, Fox at impasse; blackout looms

NEW YORK (Reuters) - About 13 million Time Warner Cable Inc subscribers were to lose most Fox programing at midnight on Thursday unless the cable service provider reached a last-minute deal to pay fees to News Corp to broadcast the shows.

» More Top News
A customer is served at a counter inside a foreign exchange store displaying a poster of various banknotes including the Chinese yuan or renminbi (RMB) in Hong Kong November 20, 2009. REUTERS/Bobby Yip
OUTLOOK 2010:

Be careful what you wish for

Pressure on China to loosen its grip on the yuan will continue but the U.S. should tread carefully. Here are five world market issues to watch.  Full Article 

Global Markets
Clients work out on machines at the Bally Total Fitness facility in Arvada, Colorado June 15, 2009. REUTERS/Rick Wilking

Get real with resolutions

We make them and we break them: The secret to keeping them is to avoid the impossible dream.  Full Article 

Lifestyle